Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells

Fig. 7

 A Agarose gel electrophoresis of all real-time PCR products derived from β1-integrin & B-Actin. Left to right in the gel: 50 bp ladder, 28.7µM Quercetin, 65.7 µM Quercetin, 40µM Regorafenib, 40 µM RDMP, 40 µM RDMP and 156nM siRNA, and control cells; B β1 integrin expressions in the non-resistant cells compared with the resistant LS-180 cells

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us